When ADHD and substance use disorders intersect: Relationship and treatment implications

Current Psychiatry Reports

Volumn 9, Issue 5, 2007, Pages 408-414

  Wilens, Timothy E ^a   Fusillo, Steven ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; LISDEXAMFETAMINE; METHADONE; METHYLPHENIDATE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALCOHOLISM; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; CANNABIS ADDICTION; CLINICAL ASSESSMENT; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; COMORBIDITY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CHOICE; DRUG DEPENDENCE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG METABOLISM; DRUG MISUSE; FAMILY RELATION; GENETIC RISK; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; ONSET AGE; PRACTICE GUIDELINE; PSYCHOLOGIC ASSESSMENT; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SELF HELP; SELF MEDICATION; SMOKING CESSATION; SUBSTANCE ABUSE; SYMPTOM; TOBACCO DEPENDENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; RISK FACTORS; SMOKING; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS;

EID: 35248832968     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-007-0053-3     Document Type: Review

References (53)

1. Kessler RC, Adler L, Barkley R, et al.: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006, 163:716-723.
2. Biederman J, Faraone S, Mick E: Age dependent decline of ADHD symptoms revisited: impact of remission definition and symptom subtype. Am J Psychiatry 2000, 157:816-817.
3. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994, 51:8-19.
4. Wilens T: Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk and treatment issues. Psychiatr Clin North Am 2004, 27:283-301.
5. Schubiner H, Tzelepis A, Milberger S, et al.: Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000, 61:244-251.
6. Levin FR, Evans S, Kleber HD: Prevalence of adult attention-deficit/ hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998, 52:15-25.
7. Faraone SV, Biederman J, Spencer TJ, et al.: Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006, 163:1720-1729. Quiz 1859.
8. Faraone SV, Wilens TE, Petty C, et al.: Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict 2007, 16(Suppl 1):24-34. Quiz 33-34.
9. Milberger S, Biederman J, Faraone S, et al.: ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997, 36:37-44.
10. Wilens TE, Biederman J, Mick E, et al.: Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997, 185:475-482.
11. Pomerleau O, Downey K, Stelson F, Pomerleau C: Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995, 7:373-378.
12. Carroll KM, Rounsaville BJ: History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993, 34:75-82.
13. Kolpe M, Carlson GA: Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict 2007, 16:46-48.
14. Biederman J, Wilens TE, Mick E, et al.: Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995, 152:1652-1658.
15. Mannuzza S, Klein RG, Bessler A, et al.: Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993, 50:565-576.
16. Molina B, Pelham W: Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003, 112:497-507.
17. Wilens T, Kwon A, Tanguay S, et al.: Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 2005, 14:319-328.
18. Biederman J, Wilens T, Mick E, et al.: Is ADHD a risk for psychoactive substance use disorder? Findings from a four year follow-up study. J Am Acad Child Adolesc Psychiatry 1997, 36:21-29.
19. Katusic SK, Barbaresi WJ, Colligan RC, et al.: Substance abuse among ADHD cases: a population-based birth cohort study. Paper presented at the Pediatric Academic Society. Seattle, WA; May 3-6, 2003.
20. Biederman J, Monuteaux M, Mick E, et al.: Is cigarette smoking a gateway drug to subsequent alcohol and illicit drug use disorders? A controlled study of youths with and without ADHD. Biol Psychiatry 2006, 59:258-264.
21. Wilens T, Biederman J, Mick E: Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 1998, 7:156-163.
22. Wilens TE, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of ADHD beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185.
23. Monuteaux MC, Spencer TJ, Faraone SV, et al.: A randomized clinical trial of bupropion for the prevention of smoking in youth with attention-deficit hyperactivity disorder. J Clin Psychiatry 2007, In press.
24. Brook J, Cohen P, Brook D: Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 1998, 37:322-330.
25. Kellam SG, Ensminger ME, Simon MB: Mental health in first grade and teenage drug, alcohol, and cigarette use. Drug Alcohol Depend 1980, 5:273-304.
26. Stanger C, Higgins S, Bickel W, et al.: Behavioral and emotional problems among children of cocaine- and opiate-dependent parents. J Am Acad Child Adolesc Psychiatry 1999, 38:421-428.
27. Earls F, Reich W, Jung KG, Cloninger CR: Psychopathology in children of alcoholic and antisocial parents. Alcohol Clin Exp Res 1988, 12:481-487.
28. Wilens T, Hahesy A, Biederman J, et al.: Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. Am J Addict 2005, 14:179-187.
29. Biederman J, Faraone SV, Monuteaux MC, Feighner JA: Patterns of alcohol and drug use in adolescents can be predicted by parental substance use disorders. Pediatrics 2000, 106:792-797.
30. Khantzian EJ: The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997, 4:231-244.
31. Mannuzza S, Gittelman-Klein R, Konig PH, Giampino TL: Hyperactive boys almost grown up: IV. Criminality and its relationship to psychiatric status. Arch Gen Psychiatry 1989, 46:1073-1079.
32. Wilens TE, Adamson J, Sgambati S, et al.: Do individuals with ADHD self medicate with cigarettes and substances of buse? Results from a controlled family study of ADHD. Am J Addict 2007, 16(Suppl 1):14-21. Quiz 22-23.
33. Levin ED, McClernon FJ, Rezvani AH: Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006, 184:523-539.
34. Upadhyaya HP, Rose K, Wang W, et al.: Attention deficit hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol 2005, 15:799-809.
35. Adler L, Cohen J: Diagnosis and evaluation of adults with ADHD. Psychiatr Clin North Am 2004, 27:187-201.
36. Riggs PD: Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:331-332.
37. McDermott SP, Wilens TE: Cognitive therapy for adults with ADHD. In Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults. Edited by Brown T. Washington, DC: American Psychiatric Press; 2000:569-606.
38. Safren SA, Otto M, Sprich S, et al.: Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005, 43:831-842.
39. Schubiner H, Saules KK, Arfken CL, et al.: Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002, 10:286-294.
40. Riggs PD, Hall SK, Mikulich-Gilbertson SK, et al.: A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 2004, 43:420-429.
41. Levin FR, Evans SM, Brooks DJ, et al.: Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 2006, 81:137-148.
42. Levin FR, Evans SM, Brooks DJ, Garawi F: Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug alcohol Depend 2007, 87:20-29.
43. Heil SH, Holmes HW, Bickel WK, et al.: Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 2002, 67:149-156.
44. Brady KT, Wilens TE, Adler LA, et al.: Atomoxetine treatment of adults with ADHD and comorbid alcohol abuse disorder. Paper presented at the 45th Annual Meeting of the American College of Neuropsychopharmacology. Hollywood, FL; December 3-7, 2006.
45. Wilens TE, Biederman J, Spencer TJ: Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 1997, 36:45-48.
46. Grabowski J, Roache JD, Schmitz JM, et al.: Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 1997, 17:485-488.
47. Volkow ND, Ding Y, Fowler JS, et al.: Is methylphenidate like cocaine? Studies on the pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995, 52:456-463.
48. Spencer T, Biederman J, Ciccone P, et al.: A PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short and long-acting orally administered formulations of methylphenidate in adults. Am J Psychiatry 2006, 163:387-395.
49. McCabe SE, Knight JR, Teter CJ, Wechsler H: Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 99:96-106.
50. Poulin C: Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ 2001, 165:1039-1044.
51. Teter CJ, McCabe SE, LaGrange K, et al.: Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006, 26:1501-1510.
52. Kroutil LA, Van Brunt DL, Herman-Stahl MA, et al.: Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 2006, 84:135-143.
53. Wilens T, Gignac M, Swezey A, et al.: Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 2006, 45:408-414.